GSK plc ADR buy melinda
Start price
15.09.21
/
50%
€41.25
Target price
15.09.22
€43.75
Performance (%)
-16.61%
End price
15.08.22
€34.40
Summary
This prediction ended on 15.08.22 with a price of €34.40. The prediction for GSK plc ADR disappointed with a performance of -16.61%. A total of €1.61 was paid as dividends for this prediction. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
GSK plc ADR | -1.648% | -1.648% | 9.146% |
iShares Core DAX® | 1.175% | -0.931% | 13.543% |
iShares Nasdaq 100 | 1.232% | 9.715% | 34.899% |
iShares Nikkei 225® | 1.563% | 3.040% | 8.943% |
iShares S&P 500 | 0.034% | 5.962% | 27.285% |
According to melinda what are the pros and cons of GSK plc ADR for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread GlaxoSmithKline plc ADR diskutieren
Buy mit Kursziel 35,0
In the thread Trading GlaxoSmithKline plc ADR
Buy beendet
Stopped prediction by melinda for GSK plc ADR
GSK plc ADR
Start price
Target price
Perf. (%)
€31.40
22.06.23
22.06.23
€35.00
22.06.24
22.06.24
19.11%
23.06.24
23.06.24
Could be worthwhile Investment >10% per year